Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET-guided high-dose vitamin C with radionuclide therapy in advanced thyroid, neuroendocrine and prostate cancer
ChiCTR2300076126Phase 2Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ascorbic acid in thyroid cancer, apudoma (NET), prostate cancer (PCa) and 1 more, sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Objective response rate. Started Aug 2023; status: recruiting.
02
Drugs
ascorbic acid
03
Conditions
thyroid cancerapudoma (NET)prostate cancer (PCa)advanced nonhematological malignancy
Beyond the preview
Go deeper on ChiCTR2300076126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076126.